Chemours Book Value Per Share Growth & History (CC)
Chemours's book value per share was $1.67 for fiscal 2025.
View full Chemours company overviewChemours annual book value per share history
| Fiscal year | Period ended | Book value per share | Change | Growth |
|---|---|---|---|---|
| 2025 | 2025-12-31 | $1.67 | -$2.15 | −56.35% |
| 2024 | 2024-12-31 | $3.82 | -$1.03 | −21.25% |
| 2023 | 2023-12-31 | $4.85 | -$2.60 | −34.91% |
| 2022 | 2022-12-31 | $7.45 | $0.74 | +11.05% |
| 2021 | 2021-12-31 | $6.71 | $1.78 | +36.16% |
| 2020 | 2020-12-31 | $4.93 | $0.72 | +17.03% |
| 2019 | 2019-12-31 | $4.21 | -$1.73 | −29.06% |
| 2018 | 2018-12-31 | $5.94 | $1.24 | +26.31% |
| 2017 | 2017-12-31 | $4.70 | $4.15 | +758.33% |
| 2016 | 2016-12-31 | $0.55 | -$0.15 | −21.30% |
| 2015 | 2015-12-31 | $0.70 | -$19.58 | −96.57% |
| 2014 | 2014-12-31 | $20.27 | $2.50 | +14.05% |
| 2013 | 2013-12-31 | $17.78 | — | — |
Chemours quarterly book value per share
| Fiscal quarter | Period ended | Book value per share | Change | YoY change |
|---|---|---|---|---|
| Q2 2026 | 2026-06-30 | -$0.33 | -$1.85 | — |
| Q1 2026 | 2026-03-31 | $1.43 | -$2.35 | −62.21% |
| Q4 2025 | 2025-12-31 | $1.67 | -$2.15 | −56.35% |
| Q3 2025 | 2025-09-30 | $1.83 | -$2.48 | −57.52% |
| Q2 2025 | 2025-06-30 | $1.52 | -$3.26 | −68.16% |
| Q1 2025 | 2025-03-31 | $3.78 | -$1.28 | −25.23% |
| Q4 2024 | 2024-12-31 | $3.82 | -$1.03 | −21.25% |
| Q3 2024 | 2024-09-30 | $4.30 | -$0.78 | −15.42% |
| Q2 2024 | 2024-06-30 | $4.78 | -$0.67 | −12.24% |
| Q1 2024 | 2024-03-31 | $5.06 | -$3.17 | −38.50% |
| Q4 2023 | 2023-12-31 | $4.85 | -$2.60 | −34.91% |
| Q3 2023 | 2023-09-30 | $5.09 | -$3.30 | −39.33% |
| Q2 2023 | 2023-06-30 | $5.45 | -$2.35 | −30.15% |
| Q1 2023 | 2023-03-31 | $8.23 | $0.79 | +10.69% |
| Q4 2022 | 2022-12-31 | $7.45 | $0.74 | +11.05% |
| Q3 2022 | 2022-09-30 | $8.39 | $2.29 | +37.54% |
| Q2 2022 | 2022-06-30 | $7.80 | $2.37 | +43.71% |
| Q1 2022 | 2022-03-31 | $7.43 | $2.30 | +44.72% |
| Q4 2021 | 2021-12-31 | $6.71 | $1.78 | +36.16% |
| Q3 2021 | 2021-09-30 | $6.10 | $1.65 | +37.01% |
| Q2 2021 | 2021-06-30 | $5.43 | $1.43 | +35.74% |
| Q1 2021 | 2021-03-31 | $5.14 | $1.15 | +28.79% |
| Q4 2020 | 2020-12-31 | $4.93 | $0.72 | +17.03% |
| Q3 2020 | 2020-09-30 | $4.45 | -$0.67 | −13.06% |
| Q2 2020 | 2020-06-30 | $4.00 | -$1.03 | −20.53% |
| Q1 2020 | 2020-03-31 | $3.99 | -$0.92 | −18.76% |
| Q4 2019 | 2019-12-31 | $4.21 | -$1.73 | −29.06% |
| Q3 2019 | 2019-09-30 | $5.12 | -$1.44 | −21.93% |
| Q2 2019 | 2019-06-30 | $5.03 | -$0.74 | −12.79% |
| Q1 2019 | 2019-03-31 | $4.91 | -$0.67 | −12.09% |
| Q4 2018 | 2018-12-31 | $5.94 | $1.24 | +26.31% |
| Q3 2018 | 2018-09-30 | $6.56 | $2.24 | +51.72% |
| Q2 2018 | 2018-06-30 | $5.77 | $2.70 | +88.15% |
| Q1 2018 | 2018-03-31 | $5.58 | $3.67 | +191.81% |
| Q4 2017 | 2017-12-31 | $4.70 | $4.15 | +758.33% |
| Q3 2017 | 2017-09-30 | $4.32 | $2.25 | +108.34% |
| Q2 2017 | 2017-06-30 | $3.07 | $2.16 | +237.48% |
| Q1 2017 | 2017-03-31 | $1.91 | $0.88 | +84.71% |
| Q4 2016 | 2016-12-31 | $0.55 | -$0.15 | −21.30% |
| Q3 2016 | 2016-09-30 | $2.07 | $1.60 | +336.56% |
| Q2 2016 | 2016-06-30 | $0.91 | -$1.31 | −58.97% |
| Q1 2016 | 2016-03-31 | $1.04 | — | — |
| Q4 2015 | 2015-12-31 | $0.70 | — | — |
| Q3 2015 | 2015-09-30 | $0.48 | — | — |
| Q2 2015 | 2015-06-30 | $2.22 | — | — |
Chemours book value per share trends
Over the last five fiscal years, Chemours's book value per share decreased from $4.93 to $1.67, a change of -$3.26. The latest reported quarter, Q2 2026, shows -$0.33.
What book value per share means
Book value per share estimates the common shareholders’ accounting equity represented by each share. It can help compare a company’s balance-sheet value over time, although market value can differ substantially from book value.
How book value per share is calculated
TickerStat calculates book value per share as SEC-reported common shareholders’ equity divided by reported period-end common shares. Preferred equity is subtracted when separately reported, and basic weighted-average shares are used only when period-end shares are unavailable. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review Chemours source filings ↗Community posts
Chemours, DuPont and Corteva agree to a $455 million PFAS settlement
Chemours ($CC), DuPont ($DD) and Corteva ($CTVA) reached an agreement to resolve PFAS-related claims brought by North Carolina and 11 local government entities. The settlement provides for $455 million in nominal payments over 15 years. Che ...